Effectiveness of a Messenger RNA Vaccine Booster Dose Against Coronavirus Disease 2019 Among US Healthcare Personnel, October 2021-July 2022.

Saved in:
Bibliographic Details
Title: Effectiveness of a Messenger RNA Vaccine Booster Dose Against Coronavirus Disease 2019 Among US Healthcare Personnel, October 2021-July 2022.
Authors: Plumb ID; National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Mohr NM; Department of Emergency Medicine, University of Iowa, Iowa City, Iowa, USA., Hagen M; National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Wiegand R; National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Dumyati G; New York State Emerging Infections Program, University of Rochester Medical Center, Rochester, New York, USA., Harland KK; Department of Emergency Medicine, University of Iowa, Iowa City, Iowa, USA., Krishnadasan A; Department of Emergency Medicine, Olive View-UCLA Education and Research Institute, Los Angeles, California, USA., Gist JJ; National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Abedi G; National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Fleming-Dutra KE; National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Chea N; National Center for Emerging and Zoonotic Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA., Lee J; Healthcare-Associated Infections, California Emerging Infections Program, Oakland, California, USA., Barter D; Healthcare-associated Infections / Antimicrobial Resistance Program, Colorado Department of Public Health & Environment, Denver, Colorado, USA., Brackney M; Connecticut Emerging Infections Program, Yale School of Public Health, New Haven, Connecticut, USA., Fridkin SK; Georgia Emerging Infections Program and Emory University School of Medicine, Atlanta, Georgia, USA., Wilson LE; Maryland Emerging Infections Program, Maryland Department of Health, and University of Maryland, Baltimore County, Baltimore, Maryland, USA., Lovett SA; Infectious Disease Epidemiology, Prevention and Control Divison, Minnesota Department of Health, St. Paul, Minnesota, USA., Ocampo V; Public Health Division, Oregon Health Authority, Portland, Oregon, USA., Phipps EC; New Mexico Emerging Infections Program, University of New Mexico, Albuquerque, New Mexico, USA., Marcus TM; Department of Health Policy, Vanderbilt University Medical Center, Nashville, Tennessee, USA., Smithline HA; Department of Emergency Medicine, University of Massachusetts Chan Medical School - Baystate, Springfield, Massachusetts, USA., Hou PC; Department of Emergency Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA., Lee LC; Emergency Medicine, Jackson Memorial Hospital, Miami, Florida, USA., Moran GJ; David Geffen School of Medicine, UCLA, Los Angeles, California, USA., Krebs E; Emergency Medicine, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA., Steele MT; Department of Emergency Medicine, University of Missouri-Kansas City, Kansas City, Missouri, USA., Lim SC; Section of Emergency Medicine, University Medical Center New Orleans, LSU Health Sciences Center, New Orleans, Louisiana, USA., Schrading WA; Department of Emergency Medicine, University of Alabama at Birmingham, Birmingham, Alabama, USA., Chinnock B; Department of Emergency Medicine, University of California San Francisco, Fresno, California, USA., Beiser DG; Section of Emergency Medicine, University of Chicago, Chicago, Illinois, USA., Faine B; Department of Emergency Medicine, University of Iowa, Iowa City, Iowa, USA., Haran JP; Department of Emergency Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA., Nandi U; Department of Emergency Medicine, University of Mississippi Medical Center, Jackson, Mississippi, USA., Chipman AK; Emergency Department, University of Washington, Seattle, Washington, USA., LoVecchio F; Emergency Medicine, Valleywise Health Medical Center, Phoenix, Arizona, USA., Talan DA; David Geffen School of Medicine, UCLA, Los Angeles, California, USA., Pilishvili T; National Center for Immunizations and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
Source: Open forum infectious diseases [Open Forum Infect Dis] 2023 Sep 08; Vol. 10 (10), pp. ofad457. Date of Electronic Publication: 2023 Sep 08 (Print Publication: 2023).
Publication Type: Journal Article
Journal Info: Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2328-8957
DOI:10.1093/ofid/ofad457